SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-06-006232
Filing Date
2006-04-25
Accepted
2006-04-25 17:28:15
Documents
6
Period of Report
2006-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SCICLONE PHARMACEUTICALS 8-K 04-23-2006 form8-k.htm 8-K 42603
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 30766
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 49577
4 EXHIBIT 99.3 ex99_3.htm EX-99.3 77416
5 EXHIBIT 99.4 ex99_4.htm EX-99.4 50155
6 EXHIBIT 99.5 ex99_5.htm EX-99.5 7993
  Complete submission text file 0001140361-06-006232.txt   260196
Mailing Address 901 MARINER'S ISLAND BLVD. SUITE 205 SAN MATEO CA 94404
Business Address 901 MARINER'S ISLAND BLVD. SUITE 205 SAN MATEO CA 94404 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 06778974
SIC: 2834 Pharmaceutical Preparations